Healthcare Equipment and Supplies
Company Overview of CardioMEMS, Inc.
CardioMEMS, Inc. develops and commercializes a wireless sensing and communication technology for the human body. The company's technology platform improves the management of severe chronic cardiovascular diseases, such as heart failure, hypertension, and aneurysms. The company’s miniature wireless sensors are implanted using minimally invasive techniques, which transmit cardiac output, blood pressure, and heart rate data. It offers CardioMEMS HF System, a heart failure monitoring device; and EndoSure Wireless AAA Pressure Measurement System that is inserted during the minimally invasive endovascular repair of abdominal aortic aneurysms or AAA through a catheter into a patient's aneurysm sac,...
387 Technology Circle NW
Atlanta, GA 30313
Founded in 2000
Key Executives for CardioMEMS, Inc.
Chief Information Officer
Compensation as of Fiscal Year 2015.
CardioMEMS, Inc. Key Developments
St. Jude Medical, Inc. and CardioMEMS Announces U.S. Food and Drug Administration Approval of the CardioMEMS HF System
May 28 14
St. Jude Medical, Inc. and CardioMEMS announced U.S. Food and Drug Administration (FDA) approval of the CardioMEMS HF System. The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce HF hospital admissions when used by physicians to manage heart failure. The CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery. The CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery (PA) during a minimally invasive procedure to directly measure PA pressure. Directly measuring PA pressure via a procedure called a right-heart catheterization is a standard-of-care practice for managing worsening HF in patients who have been hospitalized. The CardioMEMS HF System allows patients to transmit the same information from their homes to their health care providers allowing for personalized and proactive management to reduce the likelihood of hospitalization. Heart failure occurs when the heart is unable to pump enough blood to meet the body's demands and blood pressure within the heart is elevated. Significant HF progression over a period of days is known as acute decompensation and leads to hospitalization. Increased PA pressures often precede indirect measures of worsening HF such as weight and blood pressure changes. The CardioMEMS HF System allows clinicians to stabilize PA pressures by proactively managing medications and other treatment options while also providing an early indication of worsening HF.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries